-
Analysis of clinical trials reveals that placebo content is rarely described
28 October 2010
A group of researchers looked into how often details are provided about the placebos given to patients in placebo-controlled trials. The answer? Very rarely.
-
The 10-point vaccine transparency approach
29 April 2020
ANH together with the British Society for Ecological Medicine calls on UK government to heed vaccine transparency
-
Pharma advertising biases journals against food supplements – Its official!
06 February 2009
Recently published study discovers what many have suspected all along, say the Orthomolecular Medicine News Service: "Pharmaceutical money buys journal influence".
-
Monsanto threatens EFSA with lawsuit to keep GM data under wraps
13 March 2013
Or is this just a charade from the world’s biggest seed company and the EU food safety regulator?
-
News Alerts: Week 25, 2016
22 June 2016
Hazardous pesticide ingredients can be kept under wraps, Smart meters recognised as a “false solution”, Could gut bacteria reverse autism?, High cholesterol does not contribute to heart disease, Monsanto to pay millions in lawsuit, Brazil says no to GM
-
News Alerts: Week 10, 2019
06 March 2019
Statin truth battle; The health of the world; 5G – no safety studies; Wheat without gluten?; Berry good for you; Monsanto trial judge bias?
-
UK vax consultation countdown
16 September 2020
Friday 18 Sept deadline for UK consultation to proposed changes to medicines law for mass covid vaccine rollout
-
UK law changes for COVID-19 mass vaccination
10 September 2020
Have your say on changes to UK medicines law planned to herald the greatest vaccination programme in British history
-
Too few irons in the fire or out of the frying pan?
10 February 2021
Why antibody-enhancement of disease (ADE) might be a ticking time bomb
-
Consumer Organisations Criticise Influence of Drug Companies (1)
10 October 2007
The pharmaceutical industry operates in a way that puts profits before public health, members of parliament (MPs) heard last week. And the regulatory authorities, which are meant to ensure the safety of drugs and protect the public, collude with the industry, they were told.